Rheumatology

Top Story

Costs for knee osteoarthritis increased during 5-year study period

July 24, 2017

From 2009 to 2014, costs related to knee osteoarthritis have increased for Medicare patients, according to findings presented at the International Society for Pharmacoeconomics and Outcomes Research Annual Meeting.

“As part of our commercialization efforts for our [osteoarthritis] OA program, we have been evaluating the financial data on the burden of this disease,” Erich Horsley, the chief business officer of Samumed, said in a press release. “OA is a chronic and debilitating disease that constitutes a significant and increasing cost factor for both payers and patients, particularly when considering the aging demographics of the United States population.”

Renflexis, a biosimilar to Remicade, launched in the US

July 24, 2017
Renflexis, a biosimilar for Remicade that was approved by the FDA in April, has now been launched in the United States, according to a company press release…
In the Journals

In autoimmune patients, shingles vaccine seen as effective for 5 years

July 24, 2017
In patients with autoimmune disease, the effectiveness of the herpes zoster vaccine appears to be attenuated after about 5 years, according to recently published
In the Journals

AAP urges renewed support for pediatric team-based care

July 24, 2017
Specific investments should be made for pediatric care practices by stakeholders, including infrastructure, education and privacy-secured technology, to meet the needs…

FDA approves self-injectable formulation of Benlysta for lupus

July 21, 2017
The FDA has approved a self-injectable formulation of Benlysta for patients with systemic lupus erythematosus, according to a company press release. “We are…
More News Headlines »
CME

The Patient with ANCA-Associated Vasculitis

No commercial support for this activity.

ANCA-associated vasculitis is a small-vessel disease associated with significant systemic manifestations. This CME…
More »
Video Perspective

VIDEO: AHCA still faces 'uphill battle' in Senate, speaker says

May 4, 2017
More »
Resource Centers
Biosimilars in the US

Biosimilars in the US

CME

The Patient with Osteoarthritis

No commercial support for this activity.

Osteoarthritis (OA) is a chronic, progressive, multifactorial, and life-long disease characterized by degenerative and…
More »
Current Issues
View the Current Issue
Healio Rheumatology
Advertisement
Advertisement